CIK 0001833141 · <br>Emerging growth company
Helus Pharma Inc.
Sign in to watch- Ticker
- HELP
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Mar 31
- Incorporated
- British Columbia, Canada
- Entity type
- other
- Phone
- (908) 764-8385
- Business address
- 100 KING STREET WEST, SUITE 5600, TORONTO, Ontario, Canada
- Former names
- CYBIN INC.
- Open-market buys, last 90 days
- $9,670,162
- in 9 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Net +$9,670,162. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-09-30 | So Eric H. L. Director | Grant or award | +248,000 | 4,713,014 | ||
| 2026-09-30 | Glavine Paul Chief Growth Officer | Grant or award | +248,000 | 4,750,191 | ||
| 2026-09-29 | Cavers Greg Chief Financial Officer | Purchase | +3,000 | $12.91 | $39K | 3,000 |
| 2026-09-21 | Halstead Michael Chief Executive Officer | Purchase | +100,000 | $13.47 | $1.3M | 168,568 |
| 2026-09-08 | Glavine Paul Chief Growth Officer | Purchase | +100,000 | $12.47 | $1.2M | 4,271,252 |
| 2026-09-08 | Glavine Paul Chief Growth Officer | Purchase | +100,000 | $12.47 | $1.2M | 4,271,252 |
| 2026-09-08 | So Eric H. L. Executive Chair | Purchase | +100,000 | $12.39 | $1.2M | 4,465,014 |
| 2026-09-04 | So Eric H. L. Executive Chair | Purchase | +100,000 | $12.09 | $1.2M | 4,365,014 |
| 2026-09-03 | Glavine Paul Chief Growth Officer | Purchase | +100,000 | $11.78 | $1.2M | 4,171,252 |
| 2026-09-01 | So Eric H. L. Executive Chair | Purchase | +95,000 | $11.81 | $1.1M | 4,265,014 |
| 2026-08-31 | Glavine Paul Chief Growth Officer | Purchase | +90,000 | $11.59 | $1.0M | 4,071,252 |
Page 1 of 1 · 11 trades